Suchergebnisse - "Feng, Hanrong"

PubPharm (6)

1

A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Huffman, B. | Feng, H. | Parmar, K. | +25

2

CHAMP1 binds to REV7/FANCV and promotes homologous recombination repair

enthalten in: Cell reports | 2022

von Li, F. | Sarangi, P. | Iyer, D. | +5

3

PICH Supports Embryonic Hematopoiesis by Suppressing a cGAS-STING-Mediated Interferon Response

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2022

von Geng, X. | Zhang, C. | Li, M. | +11

4

Acquired Resistance to KRASG12C Inhibition in Cancer

enthalten in: The New England journal of medicine | 2021

von Awad, M. | Liu, S. | Rybkin, I. | +34

CommentIn: N Engl J Med. 2021 Jun 24;384(25):2447-2449. - PMID 34161711

5

Early-life vancomycin treatment promotes airway inflammation and impairs microbiome homeostasis

enthalten in: Aging | 2019

von Yang, X. | Feng, H. | Zhan, X. | +5

6

Oleandrin induces DNA damage responses in cancer cells by suppressing the expression of Rad51

enthalten in: Oncotarget | 2016

von Bao, Z. | Tian, B. | Wang, X. | +6

1
[1]